title: Consensus on peritonitis treatment in pediatric patients?
authors.forename: C H
authors.initials: CH
authors.lastname: Schröder
authors.forename: E
authors.initials: E
authors.lastname: Rusthoven
authors.forename: L A H
authors.initials: LA
authors.lastname: Monnens
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002437:Cefazolin / Q000627:therapeutic use*; D002442:Ceftazidime / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D002648:Child; D004359:Drug Therapy, Combination; D006801:Humans; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D017410:Practice Guidelines as Topic; D014640:Vancomycin / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D014640:Vancomycin; D002442:Ceftazidime; D002437:Cefazolin